Mechanism of action of IVIG and anti-D in ITP
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 28 (3), 249-255
- https://doi.org/10.1016/s1473-0502(03)00043-0
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Anti‐D (WinRho SD™) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine productionAmerican Journal of Hematology, 2002
- Augmented humoral and anaphylactic responses in FcγRII-deficient miceNature, 1996
- Immune thrombocytopenia and Fc receptor-mediated phagocyte functionAnnals of Hematology, 1994
- CD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatmentBritish Journal of Haematology, 1990
- Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparationsThe Journal of Pediatrics, 1986
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- SUCCESSFUL RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE HAEMOLYTIC ANAEMIABritish Journal of Haematology, 1985
- Fc-depleted vs intact intravenous immunoglobulin in chronic ITPThe Journal of Pediatrics, 1984
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981